Steve Holloway, principal analyst and company director for the healthcare market research firm Signify Research, explains the key trends he is seeing in radiology enterprise imaging systems. He spoke to ITN at the 2019 Healthcare Information Management and Systems Society at (HIMSS) conference.
VIDEO: The Economics of Artificial Intelligence
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by artificial intelligence (AI) applications in radiology, as well as potential strategies for healthcare providers looking to add AI to their armamentarium, at the 2019 Society of Imaging Informatics in Medicine (SIIM) annual meeting.
At RSNA 2018, Philips Healthcare introduced Performance Bridge as an integral part of its IntelliSpace Enterprise Edition. The insights help drive improvements and efficiencies.
This is an example of an arterial venous malformation (AVM) in the brain imaged on a Canon Alphenix Alpha angiography system. It shjows a contrast injection highlighting the vessels, which have been color coded to show the position of the veins and arteries involved in this vascular defect.
In this video Johann Fernando, Ph.D., Chief Operating Officer of FUJIFILM Medical Systems U.S.A., Inc. discusses his vision for Fujifilm as an end-to-end imaging partner -- offering high quality solutions for diagnostic imaging, treatment planning, treatment follow-up, and enterprise imaging management. He also shares his point-of-view on developing patient-centric solutions catering to the unique needs for specialized patient populations including solutions for pediatrics and imaging solutions dedicated to the operating room.
ITN Contributing Editor Greg Freiherr discusses Fujifilm's AI-enabled Platform REiLI, the benefits of an open AI platform, and how this impacts radiologists' workflow and patient outcomes with FUJIFILM Medical Systems U.S.A., Inc. Vice President of Medical Informatics, Bill Lacy.
Missed your chance for a REiLI demo at RSNA? Visit Fujifilm's booth #4159 at HIMSS February 12–14, 2019.
Artificial intelligence can do more than assist in the interpretation of patient images. At RSNA 2018, Imalogix showed how its unique AI application can help meet compliance requirements, directly improve patient safety and increase efficiencies.
Related Artificial Intelligence Content
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., professor of surgery at the Medical College of Wisconsin, discuss the factors in deciding how to treat patients with marginally operable non-small cell lung cancer at the 2018 Radiological Society of North America (RSNA) annual meeting.
- Varian’s new Bravos afterloader system for high-dose-rate (HDR) brachytherapy;
- Varian’s new ProBeam 360 single-room proton therapy system, with its lower-cost, 30 percent smaller footprint;
- The company’s vision of — and development work towards — an artificial intelligence-powered multimodality adaptive radiotherapy suite; and
- Pre-clinical research into ultra-high-dose-rate cancer treatment with protons.
In Artificial Intelligence 2018: What Radiologists Need to Know About AI, ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence (AI) advances at the Radiological Society of North America (RSNA) 2018 annual meeting.
Related Artificial Intelligence Content
In Enterprise Imaging 2018: Balancing Strategy and Technology in Enterprise Imaging, ITN Contributing Editor Greg Freiherr offers an overview of enterprise imaging advances at the Radiological Society of North America (RSNA) 2018 annual meeting.
Related Enterprise Imaging Content:
Julius Chapiro, M.D., research faculty member and an interventional radiology resident at Yale University, describes how artificial intelligence (AI) can be used to revolutionize cancer diagnosis and treatment at the 2018 Radiological Society of North America (RSNA) annual meeting.
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced clinical confidence for radiologists. ABUS can play an important role in early diagnosis of small, node negative, invasive cancers. Hear from Georgia Giakoumis Spear, M.D., from NorthShore University HealthSystem in the Chicagoland Area of Illinois as she speaks with Lucas Delaney, general manager for ABUS at GE Healthcare. As an early adopter of ABUS, she discusses the clinical need and her results with ABUS. She also provides her impressions of the newly introduced Invenia ABUS 2.0, and demonstrates a case utilizing the coronal view.
ITN Contributing Editor Greg Freiherr discusses how advances in digital technology are giving new meaning to the term dynamic imaging in his conversation with Konica Minolta President and CEO David Widmann.
Vinodh Kumar, M.D., and Komal Shah, M.D., associate professors of radiology at MD Anderson Cancer Center, describe how they are using virtual reality and augmented reality technologies for pre-operative planning and patient education for brain tumor cases. They presented on the technology at the 2018 Radiological Society of North America (RSNA) annual meeting.
Watch the VIDEO: Editor's Choice of Most Innovative Technology at HIMSS 2017 for more examples of augmented reality technology in healthcare.
Read the related article Virtual Reality Boosts Revenues and Patient Understanding.
Cyrus A. Raji, M.D., Ph.D., assistant professor of radiology at the Mallinckrodt Institute of Radiology at the Washington University School of Medicine in St. Louis, explains how diffusion tensor imaging (DTI), a form of magnetic resonance imaging (MRI), could help identify individuals earlier who are likely to develop Alzheimer's disease.
EIZO, which means image in Japanese, is a visual technology company that develops and manufactures high-end display solutions. EIZO has been one of the leading healthcare brands worldwide in medical imaging solutions for the digital era with over 45 years developing and manufacturing innovative display solutions designed for mission-critical applications. Keep your eyes open for the RX360 and GX560 available at the beginning of 2019.
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help medical imaging, explains how AI might be used to reduce the amount of gadolinium contrast needed for magnetic resonance imaging (MRI) exams.
Radiological Society of North America (RSNA) 2018 annual meeting keynote speaker Michael Recht, M.D., chairman of radiology at NYU Langone Health, discusses how artificial intelligence (AI) is being used at his institution to improve the patient experience, and how advanced technologies may impact radiology in the future. He also spoke on NYU's use of advanced analytics to improve workflow, speed patient throughput and how analytics justified the hiring of additional full-time employees because there were numbers supporting how they could help increase the department's bottom line.
He spoke after the opening remarks by RSNA President Vijay Rao, M.D., who highlighted how AI will likely impact radiology and become ingrained in daily workflow to help free up the radiologists to collaborate more as a doctor's doctor. Watch an interview with Rao in the VIDEO: RSNA President Says Artificial Intelligence is Hottest Tech Advancement in Radiology.
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the new technology and vendors highlighting enterprise imaging (EI) products during their coverage of Radiological Society Of North America (RSNA) 2018 meeting.
Watch the "VIDEO: RSNA Post-game Report on Artificial Intelligence" to hear insights from Fornell and Freiherr on the hottest technology trend in radiology at RSNA 2018.
Based on Mindray’s Living Technology, the Resona 7 (Sapphire), ZS3 (Diamond) and TE7 (Crystal) new ultrasound upgrades offer significant enhancements in support of the company’s commitment to providing state-of-the-art ultrasound imaging. Maher Elhihi, director of marketing, North America Ultrasound, summarizes the key benefits included in the company's Gem Series introduction.
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing artificial intelligence (AI) products or works-in-progress for this key trend during their coverage of the Radiological Society Of North America (RSNA) 2018 meeting.
Watch the "VIDEO: RSNA Post-game Report on Enterprise Imaging" to hear insights from Fornell and Freiherr on the newest generation enterprise imaging technology at RSNA 2018.
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 Radiological Society of North America (RSNA) meeting.
This is a walk around of an innovative new SPECT-CT nuclear imaging system shown at the Radiological Society Of North America (RSNA) 2018 meeting this week. It's CT system with comes in 16, 64 or 128 slice configurations. It has 12 SPECT detector robotic arms that automatically move toward the patient and use a sensor to stop a few millimeters from the skin to optimize photon counts and SPECT image quality. It also uses more sensitive CZT digital detectors, which allows either faster scan times, or use of only half the radiotracer dose of analog detector scans.
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiologist, Elizabeth Wende Breast Care, explains the details of a new study showing the benefits of mammography in elderly women at the Radiological Society of North America (RSNA) 2018 annual meeting.
Radiation therapy has become increasingly effective and safe as vendors continue to innovate technologies that benefit the patient. At ASTRO 2018, this patient-centric approach was exemplified and demonstrated not only in ways that match treatments to patients, but in how technologies can adjust to patient movement and anatomical changes, and to increase the precision of treatments. ITN Contributing Editor Greg Freiherr showcases several new technologies that are helping to advance this field.
For additional patient-centered care coverage, see:
Accuray's philosophy is to personalize treatments to exactly fit the patient. Senior Director of Marketing Andrew Delao explains this philosophy in a conversation with Greg Freiherr at ASTRO 2018.
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at the Radiological Society Of North America (RSNA) 2018 meeting. It uses a Hololens headset to register an overlay of the patient’s MR or Ct scan in the patient. The operator can use hand movements to slice through and manipulate the images.
The vendor gained an FDA indication for AR to be used in surgical planning in 2018. NovaRad is working with the FDA for a second indication for use of the AR in the operating room during procedures.
This video is jerky, slightly misaligned and the hand movements did not always respond because itwas shot with an iPhone inside the visor. The image quality and hand movements are much better when actually wearing it on your head and aligned for the specific user.
Related VR and AR Content:
This is an example of moving X-ray images displayed by Konica Minolta today at the Radiological Society Of North America (RSNA) 2018 meeting. This Dynamic Digital Radiography (DDR) technology shoots 15 frames per second for 20 seconds. The resulting 300 images are stitched together by the software to create a cine loop
This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data from numerous sources and then select medical records that are specific to a patient’s diagnosis and treatment for a defined disease state. This is Siemens’ AI-Pathway Companion introduced at the Radiological Society Of North America (RSNA) 2018 meeting. In this examples. A prostate cancer patient has all their data on a single time line that can be accessed by single clicks on the points to open reports, images, procedures or labs.
At the end of the time line it integrates AI driven clinical decision support that recommends the next course of action based on clinical guidelines. The guidelines cited can also be opened for review by the clinician.
This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound. The software, for the Voluson E10, helps evaluate the fetal heart shape, size and contractibility. A feature called Radiant Flow shows the blood flow in a 3-D view. It can also help show slow-flow blood, such as neuro-vascular circulation. This was shown for the first time at the 2018 Radiological Society of North America (RSNA) meeting.
Here is an example of how artificial intelligence (AI) is helping radiologists with faster workflow to improve care. This example from the Philips Illumeo system shows a spine CT and how the radiologist can use the tool bar to gain one-click, immediate access to three prior CT studies that will open with the exact slate slice view and orientation as the current exam. This was shown at the 2018 Radiological Society of North America (RSNA) meeting.
The FDA cleared the MaxQ AI Accipio Ix intracranial hemorrhage (ICH) detection software in November 2018. Here it is displayed at the Radiological Society of North America (RSNA) 2018 meeting.
At the 2018 Radiological Society of North America (RSNA) meeting, Hitachi showed a new computed tomography (CT) scanner designed for larger sized patients. The Scenaria View offers both 64 and 128 slice versions (it is also field upgradable from 64 to 128 later on). It has an 80 cm bore and the table has a weight capacity of 550 pounds. The X-ray tube also can achieve high energies up to 700 mA. The system has clearance in Japan and Europe and will be submitted for FDA clearance soon.
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the American Society for Radiation Oncology (ASTRO) 2018 conference. The overview includes new technologies for proton therapy, MRI-guded radiation therapy, PET-guided radiotherapy, brachytherapy, SRS quality assurance, 3-D printing and mobile connectivity to the oncology information system.
An interview with A. M. Niser Syed, M.D., medical director, radiation oncology and endocurietherapy, MemorialCare Cancer Institute, Long Beach, Calif. At the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting, he presented a study of 1,200 patients using a single session of intra-operative radiation therapy (IORT) using the Xoft X-ray emitting brachytherapy system.
Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St. Louis, Mo., explains his research on using blood tests to collect circulating lung tumor cells to assess their response to radiotherapy. This use of liquid biopsies can eliminate the need for invasive needle biopsies. He spoke on this topic at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting.
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation that needs to be delivered to treat the tumor and spare surrounding healthy tissue. Javier Torres-Roca, M.D., associate professor of radiation oncology, Moffit Cancer Center, and co-founder of the genomics company Cvergenx, spoke on this topic at the ASTRO 2018 conference.